The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications

American Heart Journal

Volumn 171, Issue 1, 2016, Pages 82-91

  Kandzari, David E ^a,h   Kario, Kazuomi ^b,h   Mahfoud, Felix ^c,h   Cohen, Sidney A ^d,e,h   Pilcher, Garrett ^d,h   Pocock, Stuart ^f,h   Townsend, Raymond ^e,h   Weber, Michael A ^g,h   Böhm, Michael ^c,h  

^a PIEDMONT HEART INSTITUTE   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c SAARLAND UNIVERSITY   (Germany)

^d MEDTRONIC INC   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g Downstate Health Sciences University   (United States)

^h NY

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECT; FOLLOW UP; HEALTH PROGRAM; HUMAN; HYPERTENSION; KIDNEY ARTERY; KIDNEY DENERVATION; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHAM PROCEDURE; AUTONOMIC DENERVATION; INNERVATION; KIDNEY; MULTICENTER STUDY (TOPIC); PROCEDURES; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; AUTONOMIC DENERVATION; HUMANS; HYPERTENSION; KIDNEY; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84952870245     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.08.021     Document Type: Article

References (56)

1. P.M. Kearney, M. Whelton, K. Reynolds, and et al. Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223
2. B.M. Egan, Y. Zhao, and R.N. Axon US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
3. D.M. Lloyd-Jones, J.C. Evans, and D. Levy Hypertension in adults across the age spectrum: current outcomes and control in the community JAMA 294 2005 466 472
4. S. Lewington, R. Clarke, N. Qizilbash, and et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
5. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, and et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
6. Y. Ostchega, S.S. Yoon, J. Hughes, and T. Louis Hypertension awareness, treatment, and control - continued disparities in adults: United States, 2005-2006 NCHS Data Brief 2008 1 8
7. P.A. Sarafidis, and G.L. Bakris Resistant hypertension: an overview of evaluation and treatment J Am Coll Cardiol 52 2008 1749 1757
8. D.A. Calhoun, D. Jones, S. Textor, and et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 e510 e526
9. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
10. G. Mancia, G. De Backer, A. Dominiczak, and et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
11. C. Rosendorff, H.R. Black, C.P. Cannon, and et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation 115 2007 2761 2788
12. R.H. Smithwick, and J.E. Thompson Splanchnicectomy for essential hypertension; results in 1,266 cases J Am Med Assoc 152 1953 1501 1504
13. C.J. Longland, and W.E. Gibb Sympathectomy in the treatment of benign and malignant hypertension; a review of 76 patients Br J Surg 41 1954 382 392
14. G.F. DiBona, and M. Esler Translational medicine: the antihypertensive effect of renal denervation Am J Physiol Regul Integr Comp Physiol 298 2010 R245 R253
15. M. Azizi, M. Sapoval, P. Gosse, and et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial Lancet 385 2015 1957 1965
16. M. Bohm, F. Mahfoud, C. Ukena, and et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension Hypertension 65 2015 766 774
17. M.D. Esler, M. Bohm, H. Sievert, and et al. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial Eur Heart J 35 2014 1752 1759
18. H. Krum, M.P. Schlaich, P.A. Sobotka, and et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study Lancet 383 2014 622 629
19. J. Rosa, P. Widimsky, P. Tousek, and et al. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study Hypertension 65 2015 407 413
20. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, and et al. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
21. D.E. Kandzari, D.L. Bhatt, S. Brar, and et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial Eur Heart J 36 2015 219 227
22. R. Sega, R. Facchetti, M. Bombelli, and et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study Circulation 111 2005 1777 1783
23. T.G. Pickering, J.E. Hall, L.J. Appel, and et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Circulation 111 2005 697 716
24. K. Kario Essential manual of 24 hour blood pressure management: from morning to nocturnal hypertension 2015 Wiley-Blackwell
25. F. Mahfoud, M. Bohm, M. Azizi, and et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design Eur Heart J 36 2015 2219 2227
26. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
27. M.N. Hill, N.H. Miller, S. Degeest, and et al. Adherence and persistence with taking medication to control high blood pressure J Am Soc Hypertens 5 2011 56 63
28. R. Asmar, M. Safar, and P. Queneau Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension Am J Hypertens 14 2001 546 552
29. J.P. Howard, A.N. Nowbar, and D.P. Francis Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report Heart 99 2013 1579 1587
30. J.P. Howard, G.D. Cole, H. Sievert, and et al. Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions Int J Cardiol 172 2014 29 35
31. G.L. Bakris, L.H. Lindholm, H.R. Black, and et al. Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial Hypertension 56 2010 824 830
32. J.D. Bisognano, G. Bakris, M.K. Nadim, and et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos pivotal trial J Am Coll Cardiol 58 2011 765 773
33. S. Czernichow, A. Zanchetti, F. Turnbull, and et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials J Hypertens 29 2011 4 16
34. Y. Zhang, X. Zhang, L. Liu, and et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial Eur Heart J 32 2011 1500 1508
35. C. Ott, F. Mahfoud, A. Schmid, and et al. Renal denervation in moderate treatment-resistant hypertension J Am Coll Cardiol 62 2013 1880 1886
36. B. Kaltenbach, J. Franke, S.C. Bertog, and et al. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study Catheter Cardiovasc Interv 81 2013 335 339
37. D.M. Lloyd-Jones, J.C. Evans, M.G. Larson, and et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community Hypertension 36 2000 594 599
38. F. Mahfoud, G. Bakris, D.L. Bhatt, and et al. Reduced blood pressure lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from pooled Symplicity HTN trials J Am Coll Cardiol 65 2015
39. S. Ewen, C. Ukena, D. Linz, and et al. Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension Hypertension 65 2015 193 199
40. M.K. Rippy, D. Zarins, N.C. Barman, and et al. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety Clin Res Cardiol 100 2011 1095 1101
41. A.R. Tzafriri, F. Mahfoud, J.H. Keating, and et al. Innervation patterns may limit response to endovascular renal denervation J Am Coll Cardiol 64 2014 1079 1087
42. K. Sakakura, E. Ladich, Q. Cheng, and et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man J Am Coll Cardiol 64 2014 635 643
43. F. Mahfoud, and D.L. Bhatt Catheter-based renal denervation: the black box procedure JACC Cardiovasc Interv 6 2013 1092 1094
44. J.R. Henegar, Y. Zhang, C. Hata, and et al. Catheter-based radiofrequency renal denervation: location effects on renal norepinephrine Am J Hypertens 28 2015 909 914
45. F. Mahfoud, S. Tunev, S. Ewen, and et al. Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation J Am Coll Cardiol 2015 [In Press]
46. D. Id, B. Kaltenbach, S.C. Bertog, and et al. Does the presence of accessory renal arteries affect the efficacy of renal denervation? JACC Cardiovasc Interv 6 2013 1085 1091
47. W.B. White, Z.S. Galis, J. Henegar, and et al. Renal denervation therapy for hypertension: pathways for moving development forward J Am Soc Hypertens 9 2015 341 350
48. M.A. Weber, A. Kirtane, L. Mauri, and et al. Renal denervation for the treatment of hypertension: making a new start, getting it right Clin Cardiol 38 2015 447 454
49. A. DeFelice, J. Willard, J. Lawrence, and et al. The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis J Hum Hypertens 22 2008 659 668
50. S.M. Al-Khatib, R.M. Califf, V. Hasselblad, and et al. Medicine. Placebo-controls in short-term clinical trials of hypertension Science 292 2001 2013 2015
51. P.A. James, S. Oparil, B.L. Carter, and et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 311 2014 507 520
52. G. Mancia, R. Fagard, K. Narkiewicz, and et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 2013 1281 1357
53. K. Shimamoto, K. Ando, T. Fujita, and et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014) Hypertens Res 37 2014 253 390
54. F.L. Sauvage, F. Saint-Marcoux, B. Duretz, and et al. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry Clin Chem 52 2006 1735 1742
55. H.H. Maurer Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology Clin Biochem 38 2005 310 318
56. T.E. Lohmeier, B. Liu, D.A. Hildebrandt, and et al. Global- and renal-specific sympathoinhibition in aldosterone hypertension Hypertension 65 2015 1223 1230